Cargando…
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial
The purpose of this study was to determine and compare the effects between injecting botulinum toxin A (BTX-A) transconjunctivally into the palpebral lobe and transcutaneously into the orbital lobe of the lacrimal gland in patients with epiphora due to lacrimal outflow obstruction. This randomized c...
Autores principales: | Lee, Andrew G., Lee, Shin-Hyo, Jang, Minsu, Lee, Sang Jae, Shin, Hyun Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911887/ https://www.ncbi.nlm.nih.gov/pubmed/33494380 http://dx.doi.org/10.3390/toxins13020077 |
Ejemplares similares
-
Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome
por: Pattanayak, Sabyasachi, et al.
Publicado: (2022) -
Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora
por: Singh, Swati, et al.
Publicado: (2019) -
Refractory Dry Eye Syndrome after Transconjunctival Excision of the Palpebral Lobe of the Lacrimal Gland
por: Lee, Yong-Jae, et al.
Publicado: (2021) -
Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection
por: Narang, Purvasha, et al.
Publicado: (2018) -
Primary Adenocarcinoma of the Lacrimal Gland
por: Baek, Sang-Oon, et al.
Publicado: (2012)